Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Nov 2015 07:00

RNS Number : 4315F
Ubisense Group PLC
12 November 2015
 

12.11.15

 

Ubisense Group PLC (the "Company")

 

Trading Update

 

Ubisense ("Ubisense" or the "Company") (LON:UBI), a market leader in enterprise location intelligence solutions, announces an update on current trading and an outlook for the current financial year ending 31 December 2015 ("FY15").

 

The Geospatial division has continued to trade satisfactorily. There is some significant deal concentration weighted towards the final weeks of FY15, in addition there is a good pipeline of opportunities to close for both FY15 and 2016. During the period the Company deployed with a number of its strategic partners, demonstrating ongoing demand for its solutions as well as validating its partner channel approach.

 

The RTLS division has been materially impacted by the recent well-publicised challenges facing the Company's large automotive customers, in Germany especially, and this has resulted in the downscaling, delay or cancellation of certain major deployment contracts and a likely lengthening of customer decision cycles in the wider industry.

 

Due to these unforeseen circumstances, there is a risk of a material revenue and subsequent profit shortfall against previous guidance for FY15. The Board's estimate is that second half revenues will now be in the range of £12.6-14.6 million (as against first half revenues of £10.4 million) and that full year FY15 revenues will therefore be in the range of £23-25 million. This range of outcomes should result in at least a small positive adjusted EBITDA for the second half, before non-recurring costs, but an adjusted EBITDA loss for the full year FY15.

 

As previously announced and as part of the stated strategic restructuring, the Board implemented some significant cost reduction initiatives early in the second half, resulting in annualised savings of £2.0 million. Given the challenging trading conditions highlighted above, the Board has decided to implement further cost actions over the coming months, with a view to achieving further annualised savings of approximately £3 million. A further exceptional charge of £1.7 million is expected in the second half of FY15 in relation to these measures, bringing the total exceptional charge in FY15 to £3.6 million.

 

Cash conversion this year has been adversely affected by restructuring costs and extended payment terms on certain contracts, impacting the collection of receivables. Gross cash at the end of October 2015 was £4.8 million, with £5.3 million drawn under the Company's available debt facilities, giving a net debt position of £0.5 million. The Company expects to remain in a gross cash, but net debt position, as at 31 December 2015. Management is in regular dialogue with its principal lender, HSBC, who remain supportive and in constructive discussion to support the Company's on-going requirements. The Board is determined to ensure that the Company's cash outflow situation is rectified though improved cash conversion in 2016, coupled with the benefits of the recent and current cost alignment initiatives.

 

Peter Harverson, Chairman designate, commented:

 

"The second half of the period has been challenging for the business, driven by macro events outside of our control. Whilst disappointing to announce a reduced revenue number, the recent signing of a new automotive OEM in Spain through Atlas Copco and other strategic wins support the Board's view that the strategy in place means the Group is well positioned moving forward.

 

In the short-term, we have made some necessary decisions to right size the cost base of the business and are focused on refining our sales strategy, in particular our partner channel development, to drive revenue growth through expanded scale and reach."

 

Contact

Ubisense Group plc Tel: + 44 (0) 1223 535170

Richard Green

Tim Gingell

 

Numis Securities Limited  Tel: + 44 (0) 207 2601000

Simon Willis, Jamie Lillywhite (Corporate Finance)

Rupert Krefting (Corporate Broking)

 

Redleaf Communications   Tel: +44 (0) 20 7382 4730

Rebecca Sanders-Hewett, Richard Gotla,

David Ison, Harriet Lynch

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDBKBDBADD
Date   Source Headline
23rd Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSInvestor Presentation
29th Jan 20217:00 amRNSContract Win
18th Jan 202111:10 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSTrading Update
6th Jan 202110:57 amRNSDirector/PDMR Shareholding
31st Dec 202012:00 pmRNSBlock listing Interim Review
31st Dec 20207:00 amRNSDisposal of Minority Interest
22nd Dec 20205:14 pmRNSHolding(s) in Company
22nd Dec 20203:46 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSContract Win
21st Dec 20208:30 amRNSCompletion of Fundraising, Acquisition & TVR
18th Dec 20205:15 pmRNSInitial Consideration Shares
18th Dec 202010:51 amRNSResult of General Meeting
8th Dec 20203:52 pmRNSHolding(s) in Company
3rd Dec 20207:00 amRNSGrant of Options
1st Dec 20202:50 pmRNSResults of Fundraising
1st Dec 20208:45 amRNSProposed Acquisition and Fundraising
28th Oct 20203:53 pmRNSChange of Registered Office
19th Oct 20207:00 amRNSIQGeo announces major contract extension
14th Sep 20207:00 amRNSInterim Results 1H 2020
7th Sep 20207:00 amRNSInvestor Presentation
3rd Sep 20207:00 amRNSIQGeo announces major new telecoms customer in USA
4th Aug 20207:00 amRNSDirectorate Change
20th Jul 20201:55 pmRNSDirectors' Dealings
14th Jul 20207:00 amRNSIQGeo Trading Update
2nd Jul 20207:00 amRNSBlock Listing Six Monthly Return
30th Jun 20207:00 amRNSIQGeo announces major contract expansion
29th Jun 202012:09 pmRNSDirectors' Dealings
15th Jun 20203:33 pmRNSResults of Annual General Meeting
8th Jun 20209:39 amRNSDirectors' Dealings
26th May 20207:00 amRNSDirectors' Dealings
21st May 20207:00 amRNSPosting of the Notice of Annual General Meeting
18th May 20203:29 pmRNSDirectors’ Dealings
13th May 20203:30 pmRNSDirector's Dealings
15th Apr 20209:27 amRNSDirector's Dealings
7th Apr 20207:00 amRNSPosting of Annual Financial Report
1st Apr 20204:18 pmRNSDirector's Dealings
30th Mar 20206:01 pmRNSDirector's Dealings
26th Mar 20207:00 amRNSTEPCO major contract expansion and COVID-19 update
24th Mar 20208:08 amRNSDirectors' Dealing
17th Mar 20204:26 pmRNSDirector's dealings
17th Mar 20204:21 pmRNSTR1 notification of major holdings
13th Mar 202010:55 amRNSDirectors' Dealings
11th Mar 20201:43 pmRNSDirector's Dealings
9th Mar 20207:00 amRNSAnnual Financial Report
3rd Feb 20202:59 pmRNSDirector's Dealing and Total Voting Rights
28th Jan 20207:00 amRNSTrading update
9th Jan 20204:30 pmRNSDirectors' dealings
2nd Jan 20205:16 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.